The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Cardiovascular Calcification Market Through 2030?

The cardiovascular calcification market has witnessed significant expansion in recent years. Its valuation is projected to rise from $1.9 billion in 2025 to $2.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. The market’s past growth can be attributed to several factors, including an aging population, the increasing prevalence of cardiovascular diseases, the expansion of diagnostic imaging infrastructure, the greater utilization of CT and MRI systems, and a growing awareness of vascular calcification risks.

The cardiovascular calcification market is anticipated to experience robust expansion over the next few years. It is forecast to reach $2.78 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This projected growth throughout the forecast period stems from factors such as increasing demand for precise cardiovascular diagnostics, rising adoption of AI-assisted imaging analysis, the expansion of minimally invasive diagnostic procedures, growing investments in preventive cardiology, and an increased focus on early intervention strategies. Prominent trends expected during this period include the rising adoption of advanced cardiovascular imaging modalities, an increase in the use of calcium scoring and risk stratification tools, the growing integration of AI in diagnostic imaging, the expansion of catheter-based diagnostic technologies, and an enhanced focus on early disease detection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33053&type=smp

Which Major Factors Are Contributing To The Development Of The Cardiovascular Calcification Market?

The growing incidence of cardiovascular diseases is projected to fuel the expansion of the cardiovascular calcification market in the future. Cardiovascular diseases are conditions that adversely affect the heart and blood vessels, leading to complications such as heart disease, stroke, and high blood pressure. The surge in cardiovascular diseases is primarily instigated by sedentary lifestyles and poor dietary choices, which elevate risks like hypertension, obesity, and arterial harm. Cardiovascular calcification assists in managing cardiovascular diseases by serving as a key marker for atherosclerosis and plaque buildup, facilitating the prompt detection of heart and vessel damage and guiding appropriate preventive or therapeutic interventions. For example, in August 2025, according to the National Institutes of Health, a US-based government agency, forecasts indicate that between 2025 and 2050, cardiovascular prevalence is anticipated to rise by 90%, mortality by 73%, and DALYs by 55%, with the number of deaths increasing from 20.5 million to 35.6 million. Thus, the escalating prevalence of cardiovascular diseases is a significant driver for the growth of the cardiovascular calcification market.

What Key Segment Areas Are Included In The Cardiovascular Calcification Market Assessment?

The cardiovascular calcification market covered in this report is segmented –

1) By Product Type: Imaging Systems; Atherectomy Devices; Stents; Transcatheter Valves

2) By Diagnosis: Computed Tomography (CT) Calcium Scoring; Echocardiography; Intravascular Ultrasound; Biomarkers

3) By Application: Coronary Artery Disease; Aortic Valve Stenosis; Peripheral Artery Disease; Chronic Kidney Disease (CKD) Related Vascular Calcification

4) By End User: Hospitals; Ambulatory Surgical Centers; Cardiac Clinics; Dialysis And Nephrology Centers

Subsegments:

1) By Imaging Systems: Magnetic Resonance Imaging; Computed Tomography Imaging; Ultrasound Imaging; Nuclear Imaging

2) By Atherectomy Devices: Rotational Atherectomy Devices; Directional Atherectomy Devices; Orbital Atherectomy Devices; Laser Atherectomy Devices

3) By Stents: Drug Eluting Stents; Bare Metal Stents; Bioabsorbable Stents; Balloon Expandable Stents

4) By Transcatheter Valves: Transcatheter Aortic Valves; Transcatheter Mitral Valves; Transcatheter Pulmonary Valves; Transcatheter Tricuspid Valves

Which Trends Are Expected To Shape The Cardiovascular Calcification Market?

Major companies operating in the cardiovascular calcification market are directing their efforts toward developing innovative solutions, such as targeted intravascular shockwave energy delivery technology, to enhance the treatment of heavily calcified lesions. This technology aims to improve lesion crossing, increase vessel compliance, and boost procedural success rates. Targeted intravascular shockwave energy delivery functions as a catheter-based therapy that releases controlled acoustic pressure waves inside blood vessels to fragment calcified plaque, all while preserving the integrity of surrounding soft tissue and the vessel itself. For instance, in March 2025, Shockwave Medical Inc., a US-based medical device company, launched a novel forward intravascular lithotripsy platform in the US, designed to transform the management of difficult-to-cross calcified lesions. This system utilizes forward sonic pressure waves to break down calcium in challenging peripheral artery lesions without the need for balloon inflation. Its purpose is to enable safe catheter advancement and vessel modification in complex PAD cases like CLTI, leading to better outcomes than traditional tools. Key advantages, as indicated by FORWARD PAD trial data, include a 99% technical success rate, minimal complications (1.1% major events), reduced risks of perforation or embolization, and improved efficiency for below-the-knee treatments.

Who Are The Major Companies Operating In The Cardiovascular Calcification Market?

Major companies operating in the cardiovascular calcification market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Royal Philips Healthcare, GE HealthCare Technologies Inc., Boston Scientific Corporation, Shimadzu Corporation, HeartFlow Inc., Aidoc Ltd., Neusoft Medical Systems Co. Ltd., Medis Medical Imaging Systems B.V., Pie Medical Imaging B.V., Canon Medical Systems Corporation, Keya Medical Technology Co. Ltd., Coreline Soft Co. Ltd., FastWave Medical Inc., Cleerly Inc., United Imaging Healthcare Co. Ltd., Zebra Medical Vision Ltd., Circle Cardiovascular Imaging Inc

Access The Complete Cardiovascular Calcification Market Report:

https://www.thebusinessresearchcompany.com/report/cardiovascular-calcification-market-report

Which Region Contributes The Most To The Cardiovascular Calcification Market?

North America was the largest region in the cardiovascular calcification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular calcification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Cardiovascular Calcification Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model